Stocks · Health care · Biological Products, (No Diagnostic Substances)

Revolution Medicines, Inc.

RVMD Clue Score22
United States Fiscal year ends December CIK 0001628171 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Anthony Mancini
26 Oct 2026
See Remarks
Sold after exercise
2,310
$186.99
$431.95K

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,310
History held since 14 Feb 2020